Quantbot Technologies LP Protagonist Therapeutics, Inc Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$7.36 - $11.17 $41,952 - $63,669	5,700 Added 570.0%	6,700 $73,000
Q3 2022 Nov 07, 2022	SELL	$7.86 - $11.71 $68,051 - $101,385	-8,658 Reduced 89.65%	1,000 $8,000
Q2 2022 Aug 09, 2022	BUY	$7.06 - $25.52 $68,185 - $246,472	9,658 New	9,658 $76,000
Q1 2022 May 16, 2022	SELL	$23.34 - $36.08 $305,847 - $472,792	-13,104 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$17.63 - $37.1 $231,023 - $486,158	13,104 New	13,104 $448,000
Q2 2021 Aug 12, 2021	SELL	$25.57 - $44.88 $24,393 - $42,815	-954 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$19.02 - $31.15 $18,145 - $29,717	954 New	954 $24,000
Q4 2020 Feb 12, 2021	SELL	$18.49 - $25.13 $5,546 - $7,539	-300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$15.19 - $22.4 $4,557 - $6,720	300 New	300 $5,000

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.